Gastroesophageal reflux disease (GERD) is one of the main causes of chronic cough. We evaluated the role of microaspiration in the pathogenesis of reflux-related cough by determining the amount of lipid-laden macrophages (LLMs) in bronchoalveolar lavage (BAL) specimens.
A total of 161 cases of chronic cough were evaluated, and 36 patients (average age 48.2 years) were recruited for this single center prospective study. Patients with a history of smoking, angiotensin converting enzyme inhibitor usage, any abnormality on pulmonary function tests, abnormal chest X-rays, occupational or environmental exposures, or upper airway cough syndrome were excluded. GERD was evaluated by 24-hour esophageal impedance-pH monitoring. BAL specimens for LLM determination were obtained from 34 patients by flexible bronchoscopy.
Patients with pathological intra-esophageal reflux according to multichannel intraluminal impedance and pH monitoring had higher LLM positivity in BAL specimens than patients without pathological reflux (8/14 in reflux positive group vs 1/22 in reflux negative group;
Our results confirm the role of the microaspiration of refluxate in the pathogenetic mechanism of chronic cough. While bronchoscopy is indicated in patients with chronic cough, in addition to the routine airway evaluation, BAL and LLM detection should be performed. LLM can be used to diagnose aspiration in reflux-related chronic cough. Future studies are needed to evaluate the response to anti-reflux medications or surgery in patients with LLM positivity.
Chronic cough is a common medical complaint. The most common causes of chronic cough (cough lasting over 8 weeks) in non-smoking adults with a normal chest radiograph include upper airway cough syndrome, gastroesophageal reflux disease, asthma and non-asthmatic eosinophilic bronchitis.
Gastroesophageal reflux disease (GERD) is one of the most common diseases in modern populations. An increased prevalence of GERD is associated with numerous factors, including lifestyle changes, such as nutritional habits, and obesity.1 The prevalence of the disease in Turkey is similar to that in Western countries, and 3 studies in Turkey showed similar prevalences ranging from 19.3% to 23%.2–4
GERD is considered to be one of the 3 main causes of chronic cough following the exclusion of parenchymal lung diseases, tobacco usage, environmental exposures and angiotensin converting enzyme inhibitor (ACEI) side effects.5 The association between GERD and chronic cough was initially based on observational studies and small treatment trials and is supported by epidemiological data.6,7 However, acid suppression with proton pump inhibitors failed to show superiority over placebo for the relief of reflux-related cough.8,9 Whether a causal relationship between these 2 conditions exists or their simultaneous occurrence is coincidental remains controversial.
Multiple mechanisms have been claimed to play a role in GERD-related cough, and cough may be provoked by the effect of refluxate on the esophagus, larynx or bronchi. There are 2 main mechanisms in the pathogenesis of reflux-related cough.10 One is named the “esophagobronchial reflex,” and it is based on shared vagal innervations of the distal esophagus and airways.11 According to this theory, distal esophageal sensory nerve terminals stimulated by refluxate activate a reflex arc resulting in cough. The other mechanism is microaspiration, in which refluxate reaches the airways through the proximal esophagus and larynx directly resulting in cough. The risk of microaspiration is thought to be increased by decreased sensitivity of the protective laryngeal and pharyngeal reflexes, impaired coordination of swallowing and esophageal dys-motility.12
Different techniques, such as simultaneous measurement of esophageal and tracheal pH, scintigraphic scans of the lungs, detection of pepsin in BAL or saliva, and detection of bile acids and lipid-laden macrophages (LLMs) in airway specimens, have been used to identify microaspiration of refluxate into airways.13–15 Studies on those measurement techniques have mostly been conducted in paediatric populations. Studies in adult populations focusing on reflux, bronchoalveolar lavage (BAL) and LLMs are limited. Clinically it would be highly advantageous to have a diagnostic test that could discriminate between respiratory symptoms and diseases caused by GERD from those with other causes.
The primary aim of our study was to evaluate the role of micro-aspiration in patients with chronic cough due to gastroesophageal reflux disease diagnosed by multichannel intraluminal impedance and pH (MII-pH) monitoring. Microaspiration was indicated by the presence of LLMs in BAL specimens. The secondary aim of this study was to assess the bronchoalveolar cell distribution in patients with gastroesophageal reflux-related chronic cough.
Patients admitted to the out-patient department of Ege University Medical Faculty Chest Disease between January 2010 and May 2011 complaining of cough lasting for 8 weeks or more were enrolled and evaluated by pulmonary and ear-nose-throat (ENT) specialists. Patients with concomitant symptoms of GERD (once a week or common heartburn and/or acid regurgitation) and pathologic reflux detected by 24-hour MII-pH monitoring were included in our study. All patients were older than 18 years of age. Written informed consent was obtained from all patients. This study was approved by the Ege University Research Ethics Committee.
The exclusion criteria were as follows: history of smoking, use of angiotensin converting enzyme inhibitors, abnormal chest X-rays, presence of ENT pathologies, abnormal pulmonary function tests with reversibility and bronchial provocation tests, occupational or environmental exposures that could lead to pulmonary problems, immunosuppression, any treatment that can cause lipid aspiration, any other disease that can lead to aspiration, and findings compatible with upper airway cough syndrome. None of the included patients had a lipid storage disease or had ever received nutritional supplementation with lipid emulsions.
A total of 161 consecutive chronic cough patients were prospectively evaluated for this study: 36 patients were included, and 125 patients were excluded for the following reasons (Figure): 65 patients due to abnormal chest X-rays, 32 patients due to abnormal pulmonary function test with reversibility or bronchoprovocation test, 24 patients due to findings compatible with upper airway cough syndrome, 3 patients due to ACEI usage and 1 patient due to environmental exposure.
Spirometry (Sensormedics 2400; Sensormedics, Yorba Linda, CA, USA) was applied to all patients. At least 3 reproducible values were obtained, and the highest value was accepted. Patients with a FEV1 value above 80% and a FEV1/FVC value above 75% were considered to have normal pulmonary function. A bronchoprovocation test with methacholine was performed if the spirometric measures were normal and was evaluated using the Cockroft concentration method with a threshold of positivity of a PC20 of 16 mg/mL.
All patients were examined for pathological reflux by 24-hour MII-pH monitoring. Patients were asked to stop proton pump inhibitors and H2 receptor blocking drugs for 7 days and to stop drugs affecting the lower esophageal sphincter for 48 hours prior to the procedure. After detection of lower esophageal sphincter localization by high-resolution manometric examination, a MII catheter (2–4–6–8–10–14–16th cm impedance rings and 5th cm pH electrode) was placed to provide a pH probe at 5 cm above the LES transnasally that was connected to a portable data recorder (Ohmega; MMS, Enschede, The Netherlands). Twenty-four-hour monitoring was carried out, and the patients were instructed to have a usual day with a regular diet and to push the symptom button whenever they had symptoms of reflux. pH changes were recorded, and the data were analysed after the test was completed. Only liquid refluxes, defined as a retrograde drop in impedance of 50% or more from the baseline, were evaluated. A pH of < 4 was defined as acidic reflux, whereas a pH of 4–7 was defined as weak acid reflux and a pH of > 7 was defined as nonacidic reflux. Normal values of total distal reflux were total reflux events ≤ 73, acid reflux events ≤ 55, weakly acid reflux events ≤ 26 and weakly alkaline reflux ≤ 1 based on the 95th percentile as the upper limit of the normal. Normal values for impedance pH monitoring were % bolus exposure (impedance parameter) and % acid exposure (pH parameter): total 1.4%; 6.3%; upright: 2.1%, 9.7%; and recumbent: 0.7%, 2.1%.16,17
Except for 4 patients who declined to give informed consent, transnasal or transoral bronchoscopic examination was performed in all patients with a fiberoptic bronchoscope (Olympus BF-2T10; Olympus Co, Tokyo, Japan). Local anaesthesia (2% lidocaine HCl, topical, maximum 10 mL) and premedication with midazolam were applied before the procedure. The bronchial branches on both sides were assessed for macroscopic abnormality. The middle lobe medial segment bronchus was wedged, and 120–150 mL saline was instilled for BAL. The lavage material was filtered before cytological examination.
BAL specimens were examined by liquid-based cytology and slides prepared on a Thinprep device were stained with Sudan Black to detect LLM positivity. The cells with cytoplasmic orangered granules was counted as positive. The pathologist who evaluated the BAL specimens was blinded to the patients’ GERD status.
All patients underwent an examination by an ENT specialist before the reflux work-up. A reflux finding score was obtained to evaluate laryngopharyngeal reflux, as described in the literature.18 A score greater than 7 was considered positive for laryngopharyngeal reflux, whereas a score greater than 11 was considered strongly suggestive of laryngopharyngeal reflux.
Statistical analyses were performed using SPSS v16 (SPSS for Windows; SPSS Inc, Chicago, IL, USA). Fisher’s exact test and χ2 test were used to compare the MII-pH monitoring data and BAL LLM positivity. Reflux index, impedance pH-metry parameters and BAL cell distribution were evaluated by nonparametric statistical analysis, as data were not normally distributed. The Mann Whitney U test was used to compare the reflux positive group to the control group.
A total of 161 patients were screened, and 36 patients were included in this study; 78% of the included patients were female, and the mean age of the patients was 48.2 ± 12.9 years. The average cough time of the patients was 35.1 ± 35.6 months (3–180 months). Thirty-four patients had never smoked, one patient had a smoking history of 3 pack-years and one had a smoking history of 4 pack-years. All patients included in this study had normal pulmonary function test values and normal bronchoprovocation test results with methacholine.
Fourteen patients (38.9%) had pathological reflux detected by MII-pH monitoring (pathological reflux [+] group). The control group was composed of 22 patients (61.1%) whose MII-pH monitoring results were considered normal (pathological reflux [−] group). In the pathological reflux group, the average incidences of different levels of reflux were as follows: total reflux, 90.4 ± 38.7; acidic reflux, 56.4 ± 27.4; weak acidic reflux, 33.7 ± 23.3; and nonacidic reflux, 0.2 ± 0.6.
A total of 25.0% (n = 9) of all patients had BAL LLM positivity. While 8 out of 14 patients (57.1%) in the pathological reflux group had LLM positivity, only one patient (4.5%) in the control group had LLM positivity. Compared with the control group, patients with pathological reflux had significantly higher BAL LLM positivity (
Reflux finding scores, which were evaluated by an ENT specialist, were significantly higher in the pathological reflux group: in the pathological reflux group median was 14 with an interquartile range (IQR) of 4; whereas in the control group median was 6 with an IQR of 8 (
When LLM-positive and LLM-negative groups were compared, the reflux finding scores were significantly higher in the LLM-positive group (median 14, IQR 4 vs median 6, IQR 8;
Considering all patients, on average, the BAL cell distribution was 87.9% for macrophages, 8.8% for lymphocytes, and 3% for neutrophils. There were no significant differences between the pathological reflux group and the control group in regard to BAL macrophage, lymphocyte, neutrophil or eosinophil distributions (
Main mechanisms of reflux associated chronic cough are the esophagobronchial vagal reflex mechanism and microaspiration. In this study we investigated the role of microaspiration in patients with gastroesophageal reflux-associated chronic cough by measuring LLM positivity in BAL specimens. Patients with pathological reflux according to MII/pH monitoring findings had significantly higher BAL LLM positivity compared to patients without pathological reflux, suggesting the importance of microaspiration. On the other hand, patients with LLM positivity had a higher incidence of total and acidic reflux compared to patients who were negative for LLM. BAL cell distributions were not different between the groups. The reflux finding scores at the pharynx and larynx scored by an ENT specialist supported the BAL findings, with a significantly high score in the pathological reflux group compared to that in the reflux-negative group. The difference in the reflux finding scores between the LLM-positive and LLM-negative patients was also statistically significant (
Early studies have mostly focused on the shared vagal innervations of the esophagus and airways as the main mechanism of chronic cough because cough episodes were temporally associated with distal esophageal acidification in patients with normal chest X-ray, bronchoscopy or laryngeal examination.19 Additionally, reflux-related cough was suppressed with esophageal lidocaine instillation or tracheal ipratropium inhalation.11 Javorkova et al20 showed that the acidification of the distal esophagus increased cough sensitivity in patients with GERD and chronic cough in comparison to healthy volunteers and patients with GERD only. This effect was also observed in asthma patients without cough or GERD.21 These findings support the concept that this reflex may not be the sole mechanism of reflux cough and that some airway disease may be needed for cough sensitivity to occur. Although in chronic cough patients, proximal esophageal reflux episodes do not seem to be different than in healthy volunteers,22 microaspiration of gastric content into the airways is considered to be one of the causes of cough. Dysfunction of the upper esophageal sphincter and insufficiency of protective laryngeal and pharyngeal reflexes may predispose patients to microaspiration.23 Simultaneous esophageal and tracheal pH drops during reflux episodes in asthma patients supports this hypothesis.13
The presence of pepsin, bile acids or LLMs in BAL specimens has been proposed as an index to establish the degree of gastric aspiration. The LLM index is mostly used to detect aspiration-induced chronic lung diseases in pediatric patients, especially in cases that are due to chronic aspiration.24 The value of that index has also been confirmed in an adult patient population with aspiration pneumonia.25 The importance of LLM positivity in assessing GERD was shown in cystic fibrosis patients with lung transplantation by Hayes et al.26 In that study, some patients underwent laparoscopic Nissen fundoplication and others underwent anti-reflux medical therapy. The LLM index was significantly lower in the surgical group. Opposing the reliability of LLM index as a marker of microaspiration, Kitz et al27 conducted a study in children with GERD related respiratory symptoms and found no association between reflux events and LLM counts. But MII was not used in this study, and also underlying pulmonary disease of the selected patient population may cause more reduction in sensitivity and specificity of LLM index.
However, LLM presence in BAL may not differentiate direct aspiration to the airways from secondary aspiration of reflux. Additionally, lipids in macrophages may include endogenous lipids as well as exogenous lipids, as observed in reflux material. Any disorder leading to pulmonary inflammation may cause LLM positivity. In our study, the patient population was carefully chosen to avoid these problems by excluding patients with any airway or lung disease, radiographic abnormality or any environmental exposure that can cause airway inflammation. Patients with bronchial obstruction, malignancy, and organic dust exposure were also excluded, as those conditions may result in endogenous lipid phagocytosis of macrophages. It must be kept in mind that in the opinion of some researchers, LLM presence in BAL may not be an adequate test for aspiration because of the absence of reference values in healthy volunteers and the probable discrepancy between observers, as it is scored visually.
In our study 6 out of 14 patients with GERD showed LLM negativity, and 1 control patient showed LLM positivity. Regarding the sensitivity and specificity of LLM positivity, there may be false negative or false positive results. Maybe these are the results of other causes of LLM positivity that are mentioned above. Also it should be kept in mind that there is no gold standard test for GERD diagnosis. Other markers, like pepsin and bile acids are also used as markers of microaspiration. In a study by Stovold et al,28 BAL pepsin levels were found to be elevated in lung transplant recipients, with the highest levels in subjects with acute vascular rejection. BAL pepsin levels of GERD patients with and without chronic cough were found to be similar and lower. In a study of Grabowski et al29 pepsin and bile acids in induced sputum of chronic cough patients were not different between GERD patients and the control group. In a study of Decalmer et al,30 BAL pepsin levels were found to be lower in chronic cough patients compared with controls, and they found no correlation between proximal and distal reflux events and BAL pepsin concentration. The results of these studies conflicts with our findings. This confliction may have some several probable methodological reasons. In the study of Grabowski et al29 GERD diagnosis was based on gastroscopy findings and treatment response, multichannel impedance, and pH-metry was not used and also pepsin levels were detected in sputum samples, not in BAL. In the study of Decalmer et al,30 selection of the study population was different, mainly considering unexplained chronic cough patients with various respiratory diagnoses or GERD including ex-smokers. It should also be kept in mind that pepsin measurement is also not validated as a marker of aspiration because of some significant methodological issues, like cross reaction of the immunologic assay with pepsinogen.31 For aspiration to occur, the refluxate should traverse the length of the esophagus and reach the larynx and pharynx. Although pharyngeal reflux is not prominent in chronic cough patients, our findings indicate that it may occur more often in these patients.32 Because of the technical difficulties of placement of 2 catheters or placement of an impedance catheter with 2 pH probes, proximal reflux events were not evaluated in our study. However, the reflux finding score was positive in 20 (55.6%) patients, although the accuracy of evaluating proximal esophageal reflux with this score is arguable, as it depends on a subjective visual scoring system. Limited data exist about the value of proximal pH probe monitoring in patients with chronic cough and GERD; however, many studies have shown the inefficiency of this technique for the diagnosis of laryngopharyngeal reflux.33
MII-pH monitoring for the diagnosis of GERD allowed for the detection of gaseous and weak-nonacidic reflux in addition to acidic and liquid reflux. Proximal reflux episodes and nonacidic reflux associated with cough episodes have been observed in a small portion of the patient population, and an increase in reflux episodes in patients with chronic cough compared to healthy volunteers is seldom observed. This finding indicates the possibility that even physiological reflux can provoke cough in these patients.
There was no significant difference in the BAL cell distribution between the pathological reflux group and control group or between the LLM (+) and LLM (−) groups. In a study by Chang et al,34 GERD patients without any pulmonary disease showed no difference in BAL cell distribution or LLM positivity compared with controls. According to these limited data, BAL cell distribution changes may be attributed to pulmonary diseases, not GERD itself. This study of Chang et al,34 differs from our results regarding LLM positivity. This difference may be due to difference of selected populations, as children with gastrointestinal symptoms with indication of gastroendoscopy was included in that study. Also GERD diagnosis methods and BAL were different.
Our study has some limitations. We tried to recruit patients with isolated true reflux cough: patients with any sign of airway or parenchymal disease, upper airway cough syndrome, or any other condition that can result in cough were excluded. This choice caused the patient population to be small, although it was one of the largest groups used to study this topic in the literature. Acidic and nonacidic reflux episodes were identified by MII/pH monitoring, but proximal reflux episodes were not evaluated with a proximal pH probe.
As a result, based on the hypothesis that esophagobronchial reflex and microaspiration are the 2 main mechanisms of reflux cough, our results confirm the role of refluxate microaspiration in the pathogenetic mechanism of chronic cough. In patients with chronic cough, who represents a challenging patient group in pulmonary medicine, LLM in BAL specimens may indicate the presence of microaspiration due to GERD; however, larger controlled trials are necessary to determine the reference values for this evaluation. It should be taken into consideration that although bronchoscopy is indicated in patients with chronic cough, routine airway evaluation, BAL and LLM staining should also be performed. Future studies are needed to evaluate the response to anti-reflux medications and surgery in patients with LLM positivity.
Comparison of Pathological Reflux Group and Control Group
|Pathological reflux (+)||Pathological reflux (−)|
|(n = 14)||(n = 22)|
|Age (median ± SD, yr)||46.1 ± 12.5||49.5 ± 13.2||0.445|
|Duration of cough (median ± SD, mo)||34.1 ± 16.6||35.8 ± 44.0||0.876|
|LLM (n [%])||8 (57.1)||1 (4.5)||0.004|
|BAL cell distribution (median [IQR])|
|Macrophages||91.5 (7)||90.0 (6)||0.574|
|Lymphocytes||6.0 (4)||8.0 (4)||0.348|
|Neutrophils||3.0 (4)||3.0 (3)||0.873|
|Eosinophils||0.0 (1)||0.0 (1)||0.450|
|Reflux finding score||14.0 (4)||6.0 (8)||< 0.001|
LLM, lipid-laden macrophage; BAL, bronchoalveolar lavage; IQR, interquartile range.
Comparison of Lipid-laden Macrophage Positive and Lipid-laden Macrophage Negative Patients
|LLM (+)||LLM (−)|
|(n = 9)||(n = 27)|
|Age (median ± SD, yr)||49.0 ± 12.5||46.7 ± 13.2||0.646|
|Duration of cough (median ± SD, mo)||38.1 ± 16.7||35.0 ± 42.3||0.842|
|Reflux finding score (median [IQR])||14.0 (4)||6.0 (8)||< 0.001|
|Total reflux number (median [IQR])||76.0 (57)||43.0 (32)||0.032|
|Acidic reflux (median [IQR])||53.5 (49)||18.0 (18)||0.003|
|Weak acidic reflux (median [IQR])||20.2 (25)||26.0 (19)||0.968|
|Nonacidic reflux (median [IQR])||0.0 (0)||1.0 (4)||0.030|
|BAL cell distribution (median [IQR])|
|Macrophages||92.0 (6)||88.0 (6)||0.472|
|Lymphocytes||5.5 (5)||8.0 (3)||0.443|
|Neutrophils||2.5 (2)||3.0 (4)||0.743|
|Eosinophils||0.0 (1)||0.0 (1)||0.775|
LLM, lipid-laden macrophages; IQR, interquartile range; BAL, bronchoalveolar lavage.
Lipid-laden Macrophage Positivity According to Gastro-esophageal Reflux Disease Status
|GERD (+)||GERD (−)|
GERD, gastroesophageal reflux disease; LLM, lipid-laden macrophages. Data are presented as number of patients.